ALI, ZAHID,BUTCHER, KENNETH JOHN,BUTT, RICHARD PHILIP,FELSTEAD, STEPHEN JOHN,GLATT, SOPHIE,MCKERNAN, RUTH MITCHELL,PANESAR, MANINDER
申请号：
CA2852039
公开号：
CA2852039A1
申请日:
2012.10.19
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
The invention provides 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2- fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide or a pharmaceutically acceptable salt thereof for the treatment of a disease associated with elevated blood uric acid levels, such as hyperuricemia or gout. In another aspect the invention provides the tosylate salt of 4-[2-(5-amino-1H-pyrazol-4- yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide.
